STI Prevention

Showing 1-8 of 14 results

HPV Self-Collection: A New Option in Your Toolkit

HPV self-collection is here. FDA-approved in 2024, self-swabbing lets many patients collect their own sample in the clinic, offering a safe, evidence-based option to expand cervical cancer screening access and support patient-centered care.

Calling all providers! Help combat misinformation about birth control and abortion

Apply now to Bedsider's new video initiative, #Ask Bedsider

DoxyPEP: What providers need to know

DoxyPEP is an emerging evidence-based, low-cost tool for STI prevention. Here's what you need to know.

How young people want to learn about birth control

New study highlights how providers and parents can improve reproductive well-being with trusted information.

Research roundup: June 2023 edition

Men’s willingness to use novel birth control, characteristics of patients seeking telehealth medication abortion care, mifepristone as a potential treatment for adenomyosis, and the impact of the pill on adolescent bone health.

Research roundup: April 2021 edition

Public health benefits of widespread HPV vaccination, potential for IUDs to be placed as emergency contraception 6-14 days after unprotected vaginal sex, etonogestrel implants to help with pelvic pain, and more.

Research roundup: March 2021 edition

Importance of trans-inclusive clinics and accessible education on evidence-based self-managed abortion techniques for gender-expansive individuals, an update to the CDC’s treatment guidelines for gonococcal infection, the effects of stigma and barriers to access on abortion method preference, and more.

Research roundup: November 2020 edition

Improved patient satisfaction with the implementation of One Key Question in primary care and OB/GYN care settings, increasing access to STI screening for adolescents and young adults, the need to improve contraceptive care for patients with a history of intimate partner violence, and more.
  • Previous
  • 1(current)
  • 2
  • Next